secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001213900-23-063876
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed signs non-binding term sheet to acquire Scilex securities from Sorrento for $105M; to provide $100M DIP facility
--------------------------------------------------------------------------------

- Purchase price of $105M for Scilex common (59.7M shares), Series A preferred (29.1M shares), and warrants.
- Oramed to provide $100M Replacement DIP Facility to refinance Sorrento's existing $82M DIP; credit bid for purchase.
- Option to purchase up to 2,259,058 additional Scilex shares at $1.13 per share within 30 days of transferability.
- Stalking horse protections: break-up fee of $3.4125M and expense reimbursement up to $1M if outbid.
- Transaction subject to Bankruptcy Court approval, definitive documentation, and possible higher competing bids.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023063876/0001213900-23-063876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023063876/ea182967-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-063876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer